Mrs. Rosemary Alida Hayward, MS LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 228 Redfern Village Suite 205, St Simon Island, GA 31522 Phone: 912-638-6899 Fax: 912-635-2036 |
News Archive
An experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are associated with the disease, suggests a study in mice presented at the ANESTHESIOLOGY 2016 annual meeting.
This week the House of Representatives will take the first real step in addressing our looming fiscal crisis by bringing "The Path to Prosperity," a budget resolution for next year and beyond, to the House floor. This budget offers a clear contrast to the president's speech on Wednesday. … [A] deficit speech that doesn't even rise to the level of a plan. Missing was a credible way to curb out-of-control spending.
Questcor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has informed Questcor that the FDA will require additional time beyond the current action date of September 11, 2010 to complete its review of Questcor's supplemental new drug application for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms.
David Metzger, director of the HIV/AIDS Prevention Research Division at the University of Pennsylvania, and colleagues plan to launch a trial in China among injection drug users to determine if a drug that reduces the craving for heroin also can reduce the spread of HIV through the sharing of contaminated needles, the Philadelphia Inquirer reports.
The study, by Dr Andrew Prayle, Dr Matthew Hurley and Professor Alan Smyth in the University's Division of Child Health and reported in the British Medical Journal (BMJ), showed that out of the studies completed in the States during the course of 2009, less than one-quarter had logged their results on the ClinicalTrials.gov website.
› Verified 9 days ago